Epidemiology (HBV)

Use of Vaccine Did Not Change Face of Hepatitis B Infection

Published in Medical Letter on the CDC and FDA, October 19th, 1998

The profile of hepatitis B virus infections in the United States did not changed much between the mid-1970s and mid-1990s, despite the introduction of a vaccine, the U.S. Centers for Disease Control and Prevention (CDC) reports.

The CDC report found that the racial and ethnicity-specific prevalence of hepatitis B virus (HBV) infection remained virtually the same between 1976 and 1994 and that the estimated incidence of infection also did not change.

"The lack of reduction in the estimated number of new infections over the decade between the two surveys is not surprising," Patrick J. Coleman and colleagues of the CDC's Hepatitis Branch wrote...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (1998-10-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry